NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript
NUVA earnings call for the period ending March 31, 2019.
NuVasive
NUVA
NUVA
$62.19
$0.57
0.0%
BATS BZX Real Time Price as of May 21, 2019, 3:34 p.m.
View Interactive NUVA Charts
NuVasive develops and markets minimally invasive products and related solutions for spinal surgeries.
News & Analysis: NuVasive
The Fool has written over 100 articles on NuVasive.
All
Market Moves
Earnings
NuVasive Straightens Up to Start 2019
The spinal-surgery specialist gave investors solid performance.
Why NuVasive Stock Rose 18% in February
The spinal surgery specialist gained market share last year and expects to repeat that success in 2019.
NuVasive (NUVA) Q4 2018 Earnings Conference Call Transcript
NUVA earnings call for the period ending December 31, 2018.
NuVasive Overcomes Industry Headwinds to Finish 2018 Strong
Some revenue weakness didn't hold back the spinal surgery specialist's bottom-line growth.
Why NuVasive, Avis Budget Group, and Insperity Jumped Today
Find out what helped these stocks beat a mixed market.
Here's Why NuVasive Stock Is Soaring Today
The rumor mill is buzzing about a potential takeover offer. Here's what investors need to know.
Why NuVasive, Inc. Stock Is Sinking Today
The spinal surgical equipment maker's Q3 earnings disappointed Wall Street.
NuVasive Makes a Big Bet for 2019
The spinal surgical equipment maker sacrificed near-term earnings for long-term prospects.
NuVasive Inc (NUVA) Q3 2018 Earnings Conference Call Transcript
NUVA earnings call for the period ending September 30, 2018.
